AI Assistant
Blog
Pricing
Log In
Sign Up
The
hOCT1
and
ABCB1
polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.